The alfapump® system is not currently approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. For more information regarding the POSEIDON clinical study see www.poseidonstudy.com.
The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed.
The DSR therapy is not currently approved for clinical research in the United States or Canada. There is no link between the DSR therapy and ongoing investigations with the alfapump® system in Europe.

Clinical support

Providing world-class clinical support is integral to the values of Sequana Medical, and this is reflected in our comprehensive customer support infrastructure. Our expert clinical team provides end-to-end coverage, including pre-implant surgical training, support during implants, and post-implant training for both physicians and patients.

Dedicated team

The team is always on hand for questions and advice regarding our products. Technical assistance is also offered during the lifetime of the alfapump®.

Data specialist report

Post-implant, our dedicated in-house data specialists provide fast and precise information on pump performance, enabling physicians to tailor their patient’s treatment according to their individual needs.

Contact your Sequana Medical representative

or contact us by clicking on the button below

We would like to use cookies to better understand your use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our Privacy & Cookie Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.